Ensign Peak Advisors’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-175,572
| Closed | -$740K | – | 1973 |
|
|
2022
Q3 | $740K | Buy |
175,572
+161,531
| +1,150% | +$681K | ﹤0.01% | 1246 |
|
|
2022
Q2 | $39K | Sell |
14,041
-21,539
| -61% | -$59.8K | ﹤0.01% | 2089 |
|
|
2022
Q1 | $204K | Sell |
35,580
-117,275
| -77% | -$672K | ﹤0.01% | 1873 |
|
|
2021
Q4 | $1.4M | Buy |
152,855
+29,740
| +24% | +$272K | ﹤0.01% | 1112 |
|
|
2021
Q3 | $1.32M | Buy |
+123,115
| New | +$1.32M | ﹤0.01% | 1318 |
|
|
2020
Q3 | – | Sell |
-4,869
| Closed | -$72K | – | 1752 |
|
|
2020
Q2 | $72K | Hold |
4,869
| – | – | ﹤0.01% | 1649 |
|
|
2020
Q1 | $57K | Sell |
4,869
-5,870
| -55% | -$68.7K | ﹤0.01% | 1600 |
|
|
2019
Q4 | $253K | Buy |
+10,739
| New | +$253K | ﹤0.01% | 1608 |
|